We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RNAi-based Drug Shows Promise as Treatment for Chronic Hepatitis B

News   Nov 22, 2017 | Original story from Texas Biomedical Research Institute

 
RNAi-based Drug Shows Promise as Treatment for Chronic Hepatitis B
 
 
 

RELATED ARTICLES

Why Do Our Immune Responses Differ?

News

A study of 1,000 individuals has identified three main factors that determine how our immune responses differ. The research might help identify ways to make better vaccines and improve our understanding of autoimmune disease.

READ MORE

Keeping Score On Polygenic Risk Factors

News

A new study reports a new kind of genome analysis that could identify large fractions of the population who have a much higher risk of developing serious common diseases, including coronary artery disease, breast cancer, or type 2 diabetes.

READ MORE

Worm Study Shows How Genes Drive Aging

News

Ageing in worms mainly results from the direct action of genes and not from random wear and tear or loss of function, and the same is likely to be true in humans, according to research by UCL, Lancaster University and Queen Mary University of London scientists.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE